AAAAI Podcast: Conversations from the World of Allergy

New Epinephrine Nasal Spray

The American Academy of Allergy, Asthma & Immunology (AAAAI)

Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)